Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and pharmacodynamics in optimization of antiretroviral treatment in children with vertically acquired HIV
2007-003896-38Phase 2Active
- Sponsor
- IRCCS Ospedale Policlinico San Martino
- Start
- May 2008
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of lopinavir, ritonavir, atazanavir, fosamprenavir, nevirapine and 1 more in Human immunodeficiency virus infection type 1 and human immunodeficiency virus infection (HIV) (5 arms), sponsored by IRCCS Ospedale Policlinico San Martino. Primary endpoints: Frequent plasma concentration monitoring of major PIs and NNRTIs, Pharmacokinetic-resistance interaction and 6 more. Started May 2008; status: active.
02
Drugs
lopinavirritonaviratazanavirfosamprenavirnevirapine
03
Conditions
Human immunodeficiency virus infection type 1human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-003896-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003896-38.